Ferreira, B.; Lemos, I.; Mendes, C.; Chumbinho, B.; Silva, F.; Pereira, D.; Vigia, E.; Gonçalves, L.G.; Figueiredo, A.; Cavaco, D.;
et al. Glucagon and Glucose Availability Influence Metabolic Heterogeneity and Malignancy in Pancreatic Neuroendocrine Tumour (pNET) Cells: Novel Routes for Therapeutic Targeting. Molecules 2025, 30, 2736.
https://doi.org/10.3390/molecules30132736
AMA Style
Ferreira B, Lemos I, Mendes C, Chumbinho B, Silva F, Pereira D, Vigia E, Gonçalves LG, Figueiredo A, Cavaco D,
et al. Glucagon and Glucose Availability Influence Metabolic Heterogeneity and Malignancy in Pancreatic Neuroendocrine Tumour (pNET) Cells: Novel Routes for Therapeutic Targeting. Molecules. 2025; 30(13):2736.
https://doi.org/10.3390/molecules30132736
Chicago/Turabian Style
Ferreira, Bárbara, Isabel Lemos, Cindy Mendes, Beatriz Chumbinho, Fernanda Silva, Daniela Pereira, Emanuel Vigia, LuÃs G. Gonçalves, António Figueiredo, Daniela Cavaco,
and et al. 2025. "Glucagon and Glucose Availability Influence Metabolic Heterogeneity and Malignancy in Pancreatic Neuroendocrine Tumour (pNET) Cells: Novel Routes for Therapeutic Targeting" Molecules 30, no. 13: 2736.
https://doi.org/10.3390/molecules30132736
APA Style
Ferreira, B., Lemos, I., Mendes, C., Chumbinho, B., Silva, F., Pereira, D., Vigia, E., Gonçalves, L. G., Figueiredo, A., Cavaco, D., & Serpa, J.
(2025). Glucagon and Glucose Availability Influence Metabolic Heterogeneity and Malignancy in Pancreatic Neuroendocrine Tumour (pNET) Cells: Novel Routes for Therapeutic Targeting. Molecules, 30(13), 2736.
https://doi.org/10.3390/molecules30132736
